AVGO vs DHR: Which Is the Better Buy?
Side-by-side comparison of Broadcom Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Broadcom Inc. · Technology
$371.59
-49.9% upside to fair value
Grade C
High Quality
VS
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
QuantHub Verdict
DHR has more upside to fair value
(+13.2%).
DHR trades at a lower forward P/E
(33.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AVGO |
DHR |
| Current Price |
$371.59 |
$174.04 |
| Fair Value Estimate |
$186.35 |
$197.01 |
| Upside to Fair Value |
-49.9%
|
+13.2%
|
| Market Cap |
$1,761.8B |
$123.2B |
| Forward P/E |
70.7x
|
33.4x
|
| EV / EBITDA |
46.7x
|
20.3x
|
| Price / Sales |
25.9x
|
5.0x
|
| Price / FCF |
61.1x
|
23.3x
|
| Revenue Growth YoY |
+7.2%
|
+3.7%
|
| Gross Margin |
67.1%
|
60.7%
|
| Operating Margin |
40.9%
|
21.0%
|
| Return on Equity |
32.9%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.64%
|
4.3%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Broadcom Inc. is a leading technology company specializing in semiconductors and infrastructure software, with a strong competitive moat driven by scale, diversification, and aggressive M&A under CEO Hock E. Tan. The company has demonstrated robust revenue growth, particularly in semiconductor solutions and infrastructure software segments, with a 25% year-over-year increase recently and a five-y…
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Accumulation Zones
| Metric |
AVGO |
DHR |
| Zone Low |
$139.76 |
$147.76 |
| Zone High |
$158.40 |
$167.46 |
| In Buy Zone? |
No
|
No
|